A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) with Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Skip Navigation Links.
Please be patient while the page loads...
Not Found
The requested URL
/ndocs/wavet1d/ScriptResource.axd
was not found on this server.
© 2007 -2025 Jaeb Center for Health Research